Начало › Колоректален рак › Вирджиния › Arlington
Клинични проучвания за Колоректален рак в Arlington, VA
52 проучвания за Колоректален рак търсят участници в обекти в и около Arlington (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Inova Fair Oaks Hospital, Fairfax · на 11 мили
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Набиране на участнициФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- NEXT Virginia, Fairfax · на 11 мили
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Набиране на участнициФаза 1/2
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Virginia Cancer Specialists, PC, Fairfax · на 11 мили
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Набиране на участнициФаза 1
- ALX Center 2, Fairfax · на 11 мили
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · на 11 мили
- Virginia Cancer Specialists, PC, Reston · на 14 мили
- и още 1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Набиране на участнициФаза 1/2
- NEXT Oncology, Fairfax · на 11 мили
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 2
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · на 11 мили
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · на 11 мили
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Набиране на участнициФаза 2/3
- Local Institution - 0278, Fairfax · на 11 мили
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Набиране на участнициФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · на 11 мили
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Набиране на участнициФаза 1
- NEXT - Virginia, Fairfax · на 11 мили
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- Clinical Study Site, Fairfax · на 11 мили
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Набиране на участнициФаза 2
- Inova Schar Cancer, Fairfax · на 11 мили
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Clinical Trial Site, Fairfax · на 11 мили
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Next Virginia, Fairfax · на 11 мили
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Набиране на участнициФаза 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · на 11 мили
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · на 11 мили
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Набиране на участнициФаза 1
- NEXT Texas LLC - Virginia, Fairfax · на 11 мили
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набиране на участнициФаза 1
- Research Site, Fairfax · на 11 мили
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Набиране на участнициФаза 1/2
- Next Oncology Virginia, Fairfax · на 11 мили
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1
- NEXT Virginia, LLC, Fairfax · на 11 мили
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Набиране на участнициФаза 1/2
- NEXT, Virginia, Fairfax · на 11 мили
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · на 11 мили
Проучвания за Колоректален рак в други градове
- Houston, TX102 проучвания
- New York City, NY78 проучвания
- Nashville, TN69 проучвания
- Boston, MA63 проучвания
- Los Angeles, CA59 проучвания
- St. Louis, MO50 проучвания
- San Antonio, TX46 проучвания
- Philadelphia, PA44 проучвания
- Grand Rapids, MI40 проучвания
- Baldwin Park, CA37 проучвания
- Chicago, IL34 проучвания
- Tampa, FL34 проучвания
Други проучвания в Arlington
- Рак на белия дроб с недребноклетъчен тип104 проучвания
- Метастатичен рак53 проучвания
- Рак (всички видове)48 проучвания
- Рак на гърдата47 проучвания
- Рак на яйчниците46 проучвания
- Рак на белия дроб41 проучвания
- Ендометриален рак39 проучвания
- Рак на панкреаса33 проучвания
- Плоскоклетъчен карцином на главата и шията26 проучвания
- Дребноклетъчен белодробен рак23 проучвания
- Рак на стомаха20 проучвания
- Тройно негативен рак на гърдата20 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.